4/A

FORM 4/A SUBMISSION

Company: Tvardi Therapeutics, Inc.
Filed: July 1, 2019
Period of Report: June 4, 2019
Accession Number: 0001209191-19-039793

View Document ↗ View on SEC.gov ↗